Eagle Pharmaceuticals, Inc. (EGRX)

Eagle Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	74	380	658	607	821	601
Market Cap Growth	-54.89%	-42.14%	8.37%	-26.12%	36.70%	-24.62%
Enterprise Value	131	388	586	537	750	566
PE Ratio	6.45	10.67	-76.22	50.61	57.39	18.83
PS Ratio	0.30	1.20	3.83	3.23	4.19	2.82
PB Ratio	0.30	1.63	3.73	3.26	4.58	3.74
P/FCF Ratio	-27.10	7.53	23.57	12.45	14.88	11.50
P/OCF Ratio	-27.31	7.50	23.30	12.26	14.67	11.47
EV/Sales Ratio	0.51	1.22	3.41	2.86	3.83	2.66
EV/EBITDA Ratio	2.29	4.92	309.31	17.88	25.57	14.01
EV/EBIT Ratio	3.72	5.92	-201.00	21.26	30.39	15.40
EV/FCF Ratio	-32.94	7.67	20.99	11.01	13.59	10.84
Debt / Equity Ratio	0.28	0.27	0.15	0.18	0.22	0.28
Debt / EBITDA Ratio	1.23	0.79	13.53	1.10	1.31	1.10
Debt / FCF Ratio	-7.47	1.24	0.92	0.68	0.70	0.85
Quick Ratio	1.51	1.15	1.87	4.05	4.06	3.66
Current Ratio	2.16	1.70	2.32	4.36	4.62	4.13
Asset Turnover	0.64	0.85	0.66	0.67	0.76	0.83
Interest Coverage	5.79	16.19	-1.78	9.80	9.19	13.44
Return on Equity (ROE)	5.00%	15.50%	-4.60%	6.60%	8.10%	17.80%
Return on Assets (ROA)	3.00%	9.50%	-3.30%	4.30%	5.50%	12.40%
Return on Capital (ROIC)	5.21%	15.87%	1.37%	7.95%	6.52%	16.38%
Earnings Yield	15.67%	9.37%	-1.31%	1.98%	1.74%	5.31%
FCF Yield	-12.32%	13.28%	4.24%	8.03%	6.72%	8.70%
Buyback Yield / Dilution	-2.48%	-0.11%	5.23%	2.60%	7.46%	3.96%
Total Shareholder Return	-2.48%	-0.11%	5.23%	2.60%	7.46%	3.96%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).